Free tool
FAERS Monitor: Pemetrexed Disodium
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 214657 or its brand name (Pemetrexed Disodium, Pemetrexed Disodium). Reports on generic versions are filed under their own applications.
Reports
26,175
Serious
25,665
98% of reports
Hospitalization
12,503
Death reported
4,553
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- malignant neoplasm progression2,103
- anaemia1,501
- nausea1,248
- off label use1,239
- diarrhoea1,220
- neutropenia1,207
- disease progression1,191
- pancytopenia1,130
- thrombocytopenia1,086
- drug ineffective1,027
- vomiting947
- death943
- febrile neutropenia926
- pneumonia922
- acute kidney injury908
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 61 |
| 2005 | 50 |
| 2006 | 28 |
| 2007 | 99 |
| 2008 | 136 |
| 2009 | 310 |
| 2010 | 532 |
| 2011 | 572 |
| 2012 | 438 |
| 2013 | 273 |
| 2014 | 321 |
| 2015 | 315 |
| 2016 | 530 |
| 2017 | 629 |
| 2018 | 1,047 |
| 2019 | 1,407 |
| 2020 | 1,528 |
| 2021 | 2,005 |
| 2022 | 2,510 |
| 2023 | 2,947 |
| 2024 | 3,811 |
| 2025 | 3,625 |
| 2026 | 3,001 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,027,984 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| malignant neoplasm progressionSignal | 2,103 | 16.8 | 16.1 | 30,796 |
| pancytopeniaSignal | 1,130 | 16.6 | 15.6 | 16,217 |
| febrile neutropeniaSignal | 926 | 11.4 | 10.7 | 8,646 |
| disease progressionSignal | 1,191 | 8.2 | 7.7 | 7,442 |
| thrombocytopeniaSignal | 1,086 | 7.9 | 7.4 | 6,478 |
| neutropeniaSignal | 1,207 | 7.2 | 6.8 | 6,408 |
| anaemiaSignal | 1,501 | 6.4 | 6.1 | 6,792 |
| acute kidney injurySignal | 908 | 4.8 | 4.5 | 2,723 |
| pneumoniaSignal | 922 | 2.3 | 2.2 | 679 |
| vomiting | 947 | 1.6 | 1.5 | 229 |
| diarrhoea | 1,220 | 1.5 | 1.4 | 223 |
| nausea | 1,248 | 1.3 | 1.2 | 73 |
| off label use | 1,239 | 1.1 | 1.1 | 21 |
| death | 943 | 0.9 | 0.8 | 16 |
| drug ineffective | 1,027 | 0.6 | 0.6 | 244 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.